Mark Your Calendar to Join Us Next Year September 23-26, 2024
Hynes Convention Center in Boston,
Boston, MA
Access Today's Leading Bioprocessing Science, Technologies and Networking Opportunities in a 100% Digital Format
If you can't travel to Boston, then secure your BPI Digital Experience Pass
Get the Latest Event Updates
What's Included with the Digital Experience Pass?
Access to the ConnectMe digital event platform starting 4 weeks before the live in-person event
Send instant message or meeting requests to both in-person and digital attendees ahead of the event!
12 month access to the recorded in-person main conference presentations
After the in-person event in Boston concludes, all digital experience attendees will be able to watch the recorded presentations from the main conference agenda for a full 12 months.
Access to digital exhibition and poster hall
Learn about today's novel technologies and live chat with exhibit staff and poster presenters, all from the comfort of your home!
Access to the full attendee list (both live and digital only attendees) with video chat, instant message and meeting request functionalities
Access to the Cell & Gene Therapy Manufacturing & Commercialization US event
Your digital pass includes access to all attendees, speakers, exhibitors, posters and main conference presentation recordings (Sept 19-21) that are part of the co-located CGT US event.
Access to the Well Characterized Biologics & Biological Assays event
Your digital pass includes access to all attendees, speakers, exhibitors, posters and main conference presentation recordings that are part of the co-located Well Characterized Biologics & Biological Assays event.
BPI Digital Experience Pass
Our best-in-class ConnectMe digital event platform makes it easier than ever for you to access today's leading science, technologies and networking opportunities within the global bioprocessing community.
Whether you are participating as an attendee, sponsor, or speaker, our digital event platform is designed to help you accelerate promising biologics, cell & gene therapies towards commercial success.